Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia, Armenia, and South Africa and in a multicountry st...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, Nyasha Bakare, Mathieu Bastard, Eric Caumes, Mathilde Fréchet-Jachym, Jérôme Robert, Nicolas Veziris, Naira Khachatryan, Tinatin Kotrikadze, Armen Hayrapetyan, Zaza Avaliani, Holger J. Schünemann, Christian Lienhardt
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Centers for Disease Control and Prevention 2019-05-01
סדרה:	Emerging Infectious Diseases
נושאים:	multidrug resistant extensively drug resistant tuberculosis bedaquiline individual patient data tuberculosis and other mycobacteria
גישה מקוונת:	https://wwwnc.cdc.gov/eid/article/25/5/18-1823_article
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!